Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Reduce −25.7% | 12,342,383 | $41.51 | $512M | −4,258,125 | −$431M | |
| CEIXEUR - Consol Energy | Reduce −15.5% | 2,404,127 | $104.91 | $252M | −441,554 | +$59M | |
| BHF - Brighthouse Finl | Add +0.6% | 3,142,743 | $48.94 | $154M | +20,000 | +$6M | |
| KD - Kyndryl | Add +25.6% | 5,588,126 | $15.10 | $84M | +1,139,360 | +$25M | |
| ODP1 - The Odp | Add +6.5% | 1,614,350 | $46.15 | $75M | +98,340 | +$4M | |
| GLD - Spdr Gold Tr | Add +89.2% | 431,224 | $171.45 | $74M | +203,325 | +$33M | |
| Southwestern Energy | Add +9.5% | 10,105,610 | $6.45 | $65M | +878,960 | +$10M | |
| TECK - Teck Resources · CL B | Add +8.6% | 1,461,823 | $43.09 | $63M | +115,800 | +$6M | |
| LIVN - Livanova | Add +14.7% | 1,187,276 | $52.88 | $63M | +152,380 | +$10M | |
| THC - Tenet Healthcare | Reduce −2.2% | 911,780 | $65.89 | $60M | −20,290 | −$16M | |
| NPWR - Net Power · CL A | Add +13.0% | 2,837,110 | $15.10 | $43M | +327,110 | +$10M | |
| PKG - Graphic Packaging | Add +8.7% | 1,921,610 | $22.28 | $43M | +153,930 | +$336K | |
| WFRD - Weatherford Intl | Reduce −0.9% | 430,055 | $90.33 | $39M | −4,060 | +$10M | |
| FCNCA - First Ctzns Bancshares · CL A | Add +3.4% | 23,310 | $1,380 | $32M | +760 | +$3M | |
| SLV - Ishares Silver Tr | Add +0.2% | 1,239,700 | $20.34 | $25M | +3,070 | −$618K | |
| GPOR - Gulfport Energy | Reduce −2.2% | 210,520 | $118.66 | $25M | −4,670 | +$2M | |
| Activision Blizzard | Add +15.7% | 256,740 | $93.63 | $24M | +34,860 | +$5M | |
| DHT — | New | 2,024,820 | $10.30 | $21M | +2,024,820 | +$21M | |
| NYCBEUR - New York Cmnty Bancorp | Add +1.0% | 1,724,410 | $11.34 | $20M | +16,950 | +$363K | |
| SDRL - Seadrill 2021 | Add +35.1% | 359,895 | $44.79 | $16M | +93,410 | +$5M | |
| HRI - HERC | Add +243.7% | 127,730 | $118.94 | $15M | +90,570 | +$10M | |
| FHN - First Horizon | Reduce −0.1% | 1,297,020 | $11.02 | $14M | −1,760 | −$344K | |
| GPRO - Gopro · CL A | Add +2.3% | 2,656,460 | $3.14 | $8M | +58,560 | −$2M | |
| LKFT - Galapagos | Add +4.1% | 156,378 | $34.55 | $5M | +6,210 | −$703K | |
| Danimer Scientific · CL A | Add +2.1% | 2,602,690 | $2.07 | $5M | +52,690 | −$681K | |
| REZI - Resideo Technologies | Reduce −33.8% | 324,010 | $15.80 | $5M | −165,289 | −$4M | |
| SHC - Sotera Health | Add +6082.9% | 336,970 | $14.98 | $5M | +331,520 | +$5M | |
| OIH - Vaneck ETF Trust | Hold | 6,960 | $345.04 | $2M | — | — | |
| AAP - Advance Auto Parts | Hold | 37,570 | $55.93 | $2M | — | — | |
| GANX - Gain Therapeutics | Add +7.7% | 588,410 | $3.28 | $2M | +41,850 | −$519K | |
| COYA - Coya Therapeutics | Add +19.2% | 468,067 | $3.84 | $2M | +75,420 | +$199K | |
| FCG - First Tr Exchange-Traded Fd | Hold | 58,540 | $25.99 | $2M | — | — | |
| IVZ - Invesco Actvely Mngd Etc Fd | Hold | 96,990 | $14.95 | $1M | — | — | |
| TLIS - Talis Biomedical | New | 149,052 | $5.77 | $860K | +149,052 | +$860K | |
| OHRPEUR - Neubase Therapeutics | Hold | 136,350 | $0.8698 | $119K | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $1.34 | $47K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2023 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Black Knight | Exit | 0 | $59.73 | $80M | −1,336,800 | −$80M | |
| CPRI - Capri | Exit | 0 | $35.89 | $59M | −1,646,136 | −$59M | |
| Waverley Capital Acquis | Exit | 0 | $10.40 | $4M | −350,000 | −$4M | |
| Talis Biomedical | Exit | 0 | $0.4799 | $1M | −2,235,783 | −$1M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2